Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helen Humphries

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 4, 2014
Deciding on success criteria for predictability of pharmacokinetic parameters from in vitro studies: an analysis based on in vivo observationsKhaled Abduljalil, Theresa Cain, Helen Humphries, et al.
Clinical Pharmacology and Therapeutics|April 12, 2018
Risk-Benefit Assessment of Ethinylestradiol Using a Physiologically Based Pharmacokinetic Modeling ApproachUdoamaka Ezuruike, Helen Humphries, Maurice Dickins, et al.
Biopharmaceutics & Drug Disposition|March 4, 2017
Development of a physiologically based pharmacokinetic model to predict the effects of flavin-containing monooxygenase 3 (FMO3) polymorphisms on itopride exposureWangda Zhou, Helen Humphries, Sibylle Neuhoff, et al.
CPT: Pharmacometrics & Systems Pharmacology|October 8, 2021
Development of physiologically-based pharmacokinetic models for standard of care and newer tuberculosis drugsHelen Humphries, Lisa Almond, Alexander Berg, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 4, 2014
Deciding on success criteria for predictability of pharmacokinetic parameters from in vitro studies: an analysis based on in vivo observationsKhaled Abduljalil, Theresa Cain, Helen Humphries, et al.
Clinical Pharmacology and Therapeutics|April 12, 2018
Risk-Benefit Assessment of Ethinylestradiol Using a Physiologically Based Pharmacokinetic Modeling ApproachUdoamaka Ezuruike, Helen Humphries, Maurice Dickins, et al.
Biopharmaceutics & Drug Disposition|March 4, 2017
Development of a physiologically based pharmacokinetic model to predict the effects of flavin-containing monooxygenase 3 (FMO3) polymorphisms on itopride exposureWangda Zhou, Helen Humphries, Sibylle Neuhoff, et al.
CPT: Pharmacometrics & Systems Pharmacology|October 8, 2021
Development of physiologically-based pharmacokinetic models for standard of care and newer tuberculosis drugsHelen Humphries, Lisa Almond, Alexander Berg, et al.
Pageof 1